Skip to main content
Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
148.95
+5.18 (3.60%)
At close: Feb 27, 2026, 4:00 PM EST
148.74
-0.21 (-0.14%)
After-hours: Feb 27, 2026, 7:57 PM EST

Gilead Sciences Revenue

In the year 2025, Gilead Sciences had annual revenue of $29.44B with 2.40% growth. Gilead Sciences had revenue of $7.93B in the quarter ending December 31, 2025, with 4.70% growth.

Revenue (ttm)
$29.44B
Revenue Growth
+2.40%
P/S Ratio
6.28
Revenue / Employee
$1,731,941
Employees
17,000
Market Cap
184.91B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202529.44B689.00M2.40%
Dec 31, 202428.75B1.64B6.04%
Dec 31, 202327.12B-165.00M-0.60%
Dec 31, 202227.28B-24.00M-0.09%
Dec 31, 202127.31B2.62B10.60%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Johnson & Johnson 94.19B
Merck & Co. 65.01B
Pfizer 62.58B
AbbVie 61.16B
AstraZeneca 58.74B
Novartis AG 56.67B
Sanofi 54.85B
Novo Nordisk 48.59B
Revenue Rankings

GILD News

More News